Lidocaine Cream Application Guidelines

Dosing and Safety Considerations

• The maximum safe dose of lidocaine without epinephrine is 4.5 mg/kg in adults and 1.5-2.0 mg/kg in children, according to Praxis Medical Insights 1
• When lidocaine is combined with epinephrine, the maximum safe dose increases to 7.0 mg/kg in adults and 3.0-4.5 mg/kg in children, according to Praxis Medical Insights 1
• The total dose of all local anesthetics administered must be considered when calculating maximum safe dosage, as stated by Anaesthesia 2

Special Considerations and Precautions

• Lidocaine should not be used within 4 hours of other local anesthetic interventions to prevent cumulative toxicity, as recommended by Praxis Medical Insights 3
• For patients with cardiac disease, electrolyte disorders, seizure disorders, renal or hepatic impairment, pregnancy/breastfeeding, or neurological disorders, use lidocaine with caution, according to Anaesthesia 4
• When using lidocaine on very vascular areas, lower doses should be used due to increased systemic absorption, as advised by Praxis Medical Insights 5
• Topical 5% lidocaine medicated plasters should be removed before starting any intravenous lidocaine infusion, as recommended by Anaesthesia 4

Monitoring for Toxicity

• Early signs of lidocaine toxicity include circumoral numbness, facial tingling, slurred speech, tinnitus, and light-headedness, according to Anaesthesia 4
• More severe toxicity can progress to muscle twitching, loss of consciousness, respiratory arrest, cardiac arrhythmias, and potentially ventricular arrest, as stated by Anaesthesia 4
• If any signs of toxicity appear, discontinue use immediately and seek medical attention, as advised by Anaesthesia 4

Lidocaine Dosage and Administration Guidelines

Systemic Absorption and Toxicity

• The American Geriatrics Society recommends that lidocaine 5% patch pharmacokinetic studies have shown systemic levels remain within safe range with up to four patches in 24 hours 6, 7
• Lidocaine is contraindicated in advanced liver failure due to decreased clearance, as recommended by the American Geriatrics Society 6, 7

Lidocaine Patch Overdose Prevention

Safe Usage Guidelines

• The American College of Anaesthesiologists recommends maintaining plasma lidocaine concentrations below 5 μg/mL to avoid systemic toxicity, which can occur with excessive application, prolonged use beyond 12 hours, occlusive dressings, or concurrent use with other local anesthetics 8
• Never use lidocaine patches within 4 hours of any other local anesthetic intervention to prevent cumulative toxicity 8
• Early warning signs of toxicity appear at plasma concentrations of 5-10 μg/mL, including circumoral numbness, facial tingling, tingling of tongue/lips, tinnitus, light-headedness, and slurred speech 8
• Severe toxicity develops at concentrations above 10 μg/mL, including muscle twitching, loss of consciousness, respiratory arrest, cardiac arrhythmias, and myocardial depression 8
• Use with extreme caution or avoid in patients weighing less than 40 kg 8
• Discontinue all patches immediately and seek emergency medical attention if any signs of systemic toxicity appear 8
• Avoid combining lidocaine patches with other over-the-counter lidocaine preparations, as this increases total systemic load 8

Lidocaine Patch-Induced CNS Toxicity

Mechanism and Risk Factors

• Lidocaine has a narrow therapeutic window, with CNS toxicity beginning at plasma levels only slightly above therapeutic concentrations, affecting multiple receptor systems, including muscarinic receptors, NMDA receptors, and voltage-gated channels, which explains the neuropsychiatric manifestations, as noted by the American Society of Anesthesiologists 9, 10

Clinical Presentation

• Early warning signs of lidocaine toxicity appear at plasma concentrations of 5-10 μg/mL and include circumoral numbness, facial tingling, slurred speech, tinnitus, and auditory disturbances, light-headedness, and dizziness, as reported by the American College of Cardiology 11, 12, 13
• Confusion and altered mental status are also common manifestations of lidocaine toxicity, as noted by the American College of Cardiology 11
• Muscle twitching and tremor can occur at higher plasma concentrations, as reported by the American College of Cardiology 11

Vulnerable Populations

• Patients at higher risk of lidocaine toxicity include those with advanced liver failure, body weight <40 kg, renal dysfunction, pre-existing neurologic conditions, and age >70 years, as noted by the American College of Cardiology 11

Prevention and Management

• The FDA recommends a maximum of 3 patches for 12 hours on, 12 hours off, and warns against cumulative dosing with other local anesthetics, as reported by the Anaesthesia journal 12, 13
• Clinicians must maintain high suspicion for toxicity when any CNS symptoms appear in patients using lidocaine patches, especially with the risk factors described above, as noted by the Anaesthesia journal 9, 10

Lidocaine Administration Precautions

Contraindications and Precautions

• The American Academy of Pediatrics recommends that lidocaine should be administered with strict respect to maximum safe doses (4.5 mg/kg without epinefrina, 7 mg/kg with epinefrina), avoiding simultaneous use with other local anesthetics, and having resuscitation equipment and 20% lipid emulsion available for immediate treatment of systemic toxicity 14
• The American Academy of Pediatrics states that known allergy to amide-type anesthetics is an absolute contraindication for lidocaine administration 14
• Contaminated wounds are a contraindication for topical lidocaine applications 14

Dosage Calculations

• The Anaesthesia society recommends using ideal body weight for dosage calculations in patients with BMI >30 kg/m² 15, 16, 17
• The Anaesthesia society advises against using lidocaine IV in patients weighing less than 40 kg 15, 16, 17

Administration Techniques

• The American Academy of Pediatrics suggests tamponing lidocaine with bicarbonate before injection, warming lidocaine to body temperature, injecting slowly with a small-caliber needle, and aspirating before and during each supplemental injection 14
• The American Academy of Pediatrics recommends applying 3 mL of LET (lidocaine-epinefrina-tetracaine) for children over 17 kg or 0.175 mL/kg for children under 17 kg, waiting 10-20 minutes until the wound edges appear blanched 14

Toxicity Prevention

• The Anaesthesia society states that it is crucial to calculate the total dose of all local anesthetics administered to avoid cumulative toxicity 18
• The Anaesthesia society recommends not combining lidocaine with other local anesthetic interventions without respecting safety intervals 15, 16, 17

Emergency Preparation

• The American Academy of Pediatrics and the Anaesthesia society recommend having a complete resuscitation kit, oxygen, 20% lipid emulsion, and trained personnel available before administering lidocaine 14, 18, 19

Special Considerations

• The American Academy of Pediatrics advises using reduced doses and appropriate protocols for topical anesthesia in pediatric patients, including neonates 14
• The Anaesthesia society recommends using reduced doses in elderly and debilitated patients due to increased risk of toxicity 15, 16, 17

Seizure and Convulsion After Subcutaneous Lidocaine: Mechanism

Mechanism of CNS Toxicity

• The seizure occurred due to local anesthetic systemic toxicity (LAST), where lidocaine reached toxic plasma concentrations and caused central nervous system excitation by blocking inhibitory pathways in the brain before affecting excitatory pathways, according to the Association of Anaesthetists 20, 21
• At toxic plasma concentrations (typically >5-10 μg/mL), lidocaine preferentially blocks inhibitory neurons in the cerebral cortex before affecting excitatory pathways, resulting in unopposed excitatory activity that manifests as seizures, as stated by the Association of Anaesthetists 20, 21

Clinical Progression of Toxicity

• The Association of Anaesthetists describes a predictable progression of symptoms correlating with plasma concentrations, including early signs (5-7 μg/mL), intermediate signs (7-10 μg/mL), and severe toxicity (>10 μg/mL) 20, 22
• Severe toxicity (>10 μg/mL) can result in seizures and convulsions, loss of consciousness, respiratory arrest, and cardiac arrhythmias and cardiovascular collapse, as reported by the Association of Anaesthetists 22

Patient-Specific Risk Factors

• The Association of Anaesthetists identifies critical patient factors that predispose to toxicity even at therapeutic doses, including hepatic dysfunction, cardiac failure, low body weight (<40 kg), acidemia, hypoalbuminemia, and advanced age (>70 years) 20, 21

Lidocaine Hydrochloride Safety Assessment for Incision and Drainage

Monitoring and Contraindications

• The American Society of Anesthesiologists recommends watching for early toxicity signs during and after injection, including circumoral numbness, facial tingling, tongue tingling, tinnitus, light-headedness, and slurred speech, which appear at plasma concentrations of 5-10 μg/mL and require immediate discontinuation, as stated in the Anaesthesia journal 23
• The Anaesthesia journal suggests that patients who have received any other local anesthetic within the past 4 hours or are currently using topical lidocaine preparations should not use lidocaine, to prevent cumulative toxicity from multiple lidocaine sources 23

Lidocaine 2 % (Loxicard) Pre‑operative Dosing Guidelines

Dosing Recommendations for Adult Infiltration

Administration Technique to Minimize Toxicity

Early Toxicity Monitoring

Intravenous Lidocaine for Major Surgery

Absolute Contraindications